| Utestående aktier | 24,197,809 shares |
| Insideraktier | 14 672 420 shares |
| Insynsägande | 60,64 % |
| Totalt antal insynspersoner | 36 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
0.000 %( )
911 out of 11237Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
MetaVia Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Akash Bakshi SVP and COO, Director - [D] [O] | 884 072 | 46 530 | |
|
Charles PhD Bisgaier
Chief Scientific Off. & Chair, Director, 10% Owner -
[D]
[O]
|
1 348 914 | 1 348 914 | |
|
Dong-a St Co., Ltd
10% Owner -
|
9 995 679 | 9 995 679 | |
|
E&Healthcare Investment Fund II
10% Owner -
|
1 864 799 | 152 133 | |
|
E&Healthcare Investment Fund No.7
10% Owner -
|
1 864 799 | 98 147 | |
|
E&Investment, Inc.
10% Owner -
|
2 890 533 | 152 133 | |
|
Goldman Sachs Group Inc
10% Owner -
|
2 441 004 | 305 126 | |
| Jason L Groves Director - [D] | 45 699 | 45 699 | |
| Mark A Glickman Director - [D] | 37 887 | 37 887 | |
| Lee Scott Golden | 148 000 | ||
| Gullans Steven R. Ph.D. President & CEO, Director - [D] [O] | 300 000 | 300 000 | |
| Hawryluk P. Kent Director - [D] | 81 889 | 81 889 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
JK BioPharma Solutions, Inc
10% Owner -
|
800 170 | 42 114 | |
| Tae Heum Jeong | 60 000 | ||
| Kenneth W Kousky Director - [D] | 26 935 | 26 935 | |
| Andrew I Koven Director - [D] | 45 699 | 45 699 | |
| Jeong Gu Kang | 0 | ||
|
Sun Dae Kang
10% Owner -
|
800 170 | 42 114 | |
| Hyung Heon Kim CEO & President, Director - [D] [O] | 61 004 | 61 004 | |
|
Na Yeon Kim
Director, 10% Owner -
[D]
|
4 671 | 584 | |
| Pedro Lichtinger Director - [D] | 74 833 | 74 833 | |
| David Lowenschuss Chief Legal Off. & Secretary - [O] | 806 247 | 806 247 | |
| Jeffrey S Mathiesen Chief Financial Officer - [O] | 14 134 | 14 134 | |
|
Jeong Gyun Oh
Director, 10% Owner -
[D]
|
240 051 | 12 634 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Carmen Daniela Oniciu Vice President - [O] | 152 401 | 152 401 | |
| Ben Gil Price | 616 666 | ||
| Seth Reno Chief Commercial Officer - [O] | 118 286 | 118 286 | |
| Andy Sassine Director - [D] | 151 264 | 151 264 | |
| D Gordon Strickland Director - [D] | 45 699 | 45 699 | |
| Michael Salsbury Director - [D] | 45 699 | 45 699 | |
| Nicola Shannon | 0 | ||
| Mina Sooch President & CEO, Director - [D] [O] | 693 732 | 693 732 | |
| Douglas J Swirsky | 60 000 | ||
| James Patrick Tursi Director - [D] | 37 219 | 37 219 | |
| Mark Versavel | 45 724 | ||
| Marshall H Woodworth Chief Financial Officer - [O] | 30 079 | 30 079 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i MTVA / MetaVia Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i MTVA / MetaVia Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
| Handelsdatum | Insider | Rapporterade aktier |
Rapporterat pris |
Justerade aktier |
Justerat pris |
Kostnadsbasis | Dagar til Min |
Pris vid Min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-12 | DONG-A ST CO., LTD | 407 | 3,7500 | 407 | 3,7500 | 1 526 | 64 | 2.2200 | −622 | −40,79 |
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-13 | 2025-08-12 | 4 | Woodworth Marshall H | MTVA | Common Stock | D | −14 200 | 30 079 | ||||||
| 2025-07-01 | 2025-06-30 | 4 | GROVES JASON L | MTVA | Common Stock | D | 28 147 | 45 699 | ||||||
| 2025-07-01 | 2025-06-30 | 4 | Glickman Mark A | MTVA | Common Stock | D | 28 147 | 37 887 | ||||||
| 2025-07-01 | 2025-06-30 | 4 | STRICKLAND D GORDON | MTVA | Common Stock | D | 28 147 | 45 699 | ||||||
| 2025-07-01 | 2025-06-30 | 4 | Tursi James Patrick | MTVA | Common Stock | D | 28 147 | 37 219 | ||||||
| 2025-07-01 | 2025-06-30 | 4 | Salsbury Michael | MTVA | Common Stock | D | 28 147 | 45 699 | ||||||
| 2025-07-01 | 2025-06-30 | 4 | KOVEN ANDREW I | MTVA | Common Stock | D | 28 147 | 45 699 | ||||||
| 2025-06-04 | 2025-06-04 | 4 | Woodworth Marshall H | MTVA | Common Stock | D | 0,7000 | 14 200 | 10 | 44 279 | ||||
| 2025-05-20 | 2025-05-08 | 4 | DONG-A ST CO., LTD | MTVA | Common Stock | D | 0,7100 | 4 647 887 | 3 300 | 9 995 679 | ||||
| 2025-03-04 | 2025-03-01 | 4 | Woodworth Marshall H | MTVA | Common Stock | D | 1,4600 | −3 417 | −5 | 30 079 | ||||
| 2025-03-04 | 2025-03-01 | 4 | Kim Hyung Heon | MTVA | Common Stock | D | 1,4600 | −2 795 | −4 | 61 004 | ||||
| 2024-12-02 | 2024-11-30 | 4 | Kim Hyung Heon | MTVA | Common Stock | D | 2,5500 | −2 867 | −7 | 63 799 | ||||
| 2024-09-20 | 2024-09-12 | 4 | DONG-A ST CO., LTD | NRBO | Common Stock | D | 3,7500 | −407 | −2 | 5 347 792 | ||||
| 2024-08-13 | 2024-08-11 | 4 | Kim Hyung Heon | NRBO | Common Stock | D | 3,6000 | −11 467 | −41 | 66 666 | ||||
| 2024-07-10 | 2024-06-23 | 4/A | DONG-A ST CO., LTD | NRBO | Common Stock | D | 3,9300 | 2 544 530 | 10 000 | 5 348 229 | ||||
| 2024-06-25 | 2024-06-23 | 4 | DONG-A ST CO., LTD | NRBO | Common Stock | D | 3,1300 | 2 544 530 | 7 964 | 5 348 229 | ||||
| 2024-06-07 | 2024-06-07 | 4 | Salsbury Michael | NRBO | Common Stock | D | 5 051 | 17 552 | ||||||
| 2024-06-07 | 2024-06-07 | 4 | GROVES JASON L | NRBO | Common Stock | D | 5 051 | 17 552 | ||||||
| 2024-06-07 | 2024-06-07 | 4 | KOVEN ANDREW I | NRBO | Common Stock | D | 5 051 | 17 552 | ||||||
| 2024-06-07 | 2024-06-07 | 4 | Tursi James Patrick | NRBO | Common Stock | D | 5 051 | 9 072 | ||||||
| 2024-06-07 | 2024-06-07 | 4 | Glickman Mark A | NRBO | Common Stock | D | 5 051 | 9 740 | ||||||
| 2024-06-07 | 2024-06-07 | 4 | STRICKLAND D GORDON | NRBO | Common Stock | D | 5 051 | 17 552 | ||||||
| 2024-03-04 | 2024-03-01 | 4 | Woodworth Marshall H | NRBO | Common Stock | D | 33 496 | 33 496 | ||||||
| 2023-12-04 | 2023-12-01 | 4 | Tursi James Patrick | NRBO | Common Stock | D | 7 157 | 32 157 | ||||||
| 2023-12-04 | 2023-12-01 | 4 | Tursi James Patrick | NRBO | Common Stock | D | 25 000 | 25 000 | ||||||
| 2023-08-14 | 2023-08-11 | 4 | Kim Hyung Heon | NRBO | Common Stock | D | 625 064 | 625 064 | ||||||
| 2023-07-28 | 2023-07-27 | 4 | KOVEN ANDREW I | NRBO | Common Stock | D | 12 500 | 100 000 | ||||||
| 2023-07-28 | 2023-07-27 | 4 | KOVEN ANDREW I | NRBO | Common Stock | D | 87 500 | 87 500 | ||||||
| 2023-07-28 | 2023-07-27 | 4 | Salsbury Michael | NRBO | Common Stock | D | 12 500 | 100 000 | ||||||
| 2023-07-28 | 2023-07-27 | 4 | Salsbury Michael | NRBO | Common Stock | D | 87 500 | 87 500 | ||||||
| 2023-07-28 | 2023-07-27 | 4 | STRICKLAND D GORDON | NRBO | Common Stock | D | 12 500 | 100 000 | ||||||
| 2023-07-28 | 2023-07-27 | 4 | STRICKLAND D GORDON | NRBO | Common Stock | D | 87 500 | 87 500 | ||||||
| 2023-07-28 | 2023-07-27 | 4 | GROVES JASON L | NRBO | Common Stock | D | 12 500 | 100 000 | ||||||
| 2023-07-28 | 2023-07-27 | 4 | GROVES JASON L | NRBO | Common Stock | D | 87 500 | 87 500 | ||||||
| 2023-07-28 | 2023-07-27 | 4 | Glickman Mark A | NRBO | Common Stock | D | 12 500 | 37 500 | ||||||
| 2023-07-28 | 2023-07-27 | 4 | Glickman Mark A | NRBO | Common Stock | D | 25 000 | 25 000 | ||||||
| 2023-07-28 | 2023-07-27 | 4 | Kim Na Yeon | NRBO | Common Stock | D | 12 500 | 101 459 | ||||||
| 2023-07-28 | 2023-07-27 | 4 | Kim Na Yeon | NRBO | Common Stock | D | 87 500 | 88 959 | ||||||
| 2023-07-28 | 2022-07-26 | 4/A | Kim Na Yeon Held by E&Investment Inc. | NRBO | Common Stock | I | 4 671 | 4 671 | ||||||
| 2022-11-22 | 3 | GOLDMAN SACHS & CO See Footnotes | NRBO | Common Stock | I | 1 220 502 | ||||||||
| 2022-07-28 | 2022-07-26 | 4 | E&Investment, Inc. Held by The E&Healthcare Investment Fund II | NRBO | Common Stock | I | −1 445 267 | 2 890 533 | ||||||
| 2022-07-28 | 2022-07-26 | 4 | Kim Na Yeon Held by The E&Healthcare Investment Fund II | NRBO | Common Stock | I | −1 445 267 | 2 890 533 | ||||||
| 2022-02-02 | 2022-01-27 | 4 | STRICKLAND D GORDON | NRBO | Non-qualified Stock Option (right to buy) | D | 1,02 | 40 000 | 40 000 | |||||
| 2021-11-04 | 2021-11-03 | 4 | Price Ben Gil | NRBO | Nonstatutory Stock Option (right to buy) | D | 2,04 | 616 666 | 616 666 | |||||
| 2021-09-03 | 2021-09-02 | 4 | KOVEN ANDREW I | NRBO | Nonstatutory Stock Option (right to buy) | D | 4,52 | 60 000 | 60 000 | |||||
| 2021-01-05 | 2020-12-31 | 4 | Bakshi Akash | NRBO | Common Stock | I | 855 059 | 884 072 | ||||||
| 2021-01-05 | 2020-12-31 | 4 | Bakshi Akash | NRBO | Common Stock | D | 29 013 | 29 013 | ||||||
| 2020-09-03 | 2020-09-01 | 4 | Swirsky Douglas J | NRBO | Non-qualified stock option (right to buy) | D | 6,04 | 60 000 | 60 000 | |||||
| 2020-01-17 | 3/A | Kang Sun Dae | NRBO | Common Stock | D | 800 170 | ||||||||
| 2020-01-17 | 3/A | Kang Sun Dae | NRBO | Common Stock | D | 1 817 842 | ||||||||
| 2020-01-15 | 2020-01-13 | 4 | Kim Na Yeon | NRBO | Non-qualified stock option (right to buy) | D | 8,39 | 60 000 | 60 000 | |||||
| 2020-01-15 | 2020-01-13 | 4 | Oh Jeong Gyun | NRBO | Non-qualified stock option (right to buy) | D | 8,39 | 60 000 | 60 000 | |||||
| 2020-01-15 | 2020-01-13 | 4 | Salsbury Michael | NRBO | Non-qualified stock option (right to buy) | D | 8,39 | 60 000 | 60 000 | |||||
| 2020-01-15 | 2020-01-13 | 4 | GROVES JASON L | NRBO | Non-qualified stock option (right to buy) | D | 8,39 | 60 000 | 60 000 | |||||
| 2020-01-15 | 2020-01-13 | 4 | Gullans Steven R. Ph.D. | NRBO | Non-qualified stock option (right to buy) | D | 8,39 | 60 000 | 60 000 | |||||
| 2020-01-15 | 2020-01-13 | 4 | Jeong Tae Heum | NRBO | Non-qualified stock option (right to buy) | D | 8,39 | 60 000 | 60 000 | |||||
| 2020-01-10 | 3/A | E&Healthcare Investment Fund No.7 Held by The E&Healthcare Investment Fund No. 6 | NRBO | Common Stock | I | 1 121 190 | ||||||||
| 2020-01-10 | 3/A | E&Healthcare Investment Fund No.7 Held by The E&Healthcare Investment Fund No. 7 | NRBO | Common Stock | I | 1 864 799 | ||||||||
| 2020-01-10 | 3/A | E&Healthcare Investment Fund No.7 Held by The E&Healthcare Investment Fund II | NRBO | Common Stock | I | 4 335 800 | ||||||||
| 2020-01-09 | 3 | E&Investment, Inc. Held by The E&Healthcare Investment Fund II | NRBO | Common Stock | I | 11 657 589 | ||||||||
| 2020-01-09 | 3 | E&Investment, Inc. Held by The E&Healthcare Investment Fund No. 7 | NRBO | Common Stock | I | 9 186 588 | ||||||||
| 2020-01-09 | 3 | E&Investment, Inc. Held by The E&Healthcare Investment Fund No. 6 | NRBO | Common Stock | I | 8 442 979 | ||||||||
| 2020-01-09 | 3 | E&Investment, Inc. Held by The E&Healthcare Investment Fund II | NRBO | Common Stock | I | 11 657 589 | ||||||||
| 2020-01-09 | 3 | E&Investment, Inc. Held by The E&Healthcare Investment Fund No. 7 | NRBO | Common Stock | I | 9 186 588 | ||||||||
| 2020-01-09 | 3 | E&Investment, Inc. Held by The E&Healthcare Investment Fund No. 6 | NRBO | Common Stock | I | 8 442 979 | ||||||||
| 2020-01-09 | 3 | E&Investment, Inc. Held by The E&Healthcare Investment Fund No. 7 | NRBO | Common Stock | I | 9 186 588 | ||||||||
| 2020-01-09 | 3 | E&Investment, Inc. Held by The E&Healthcare Investment Fund No. 6 | NRBO | Common Stock | I | 8 442 979 | ||||||||
| 2020-01-09 | 3 | E&Investment, Inc. Held by The E&Healthcare Investment Fund II | NRBO | Common Stock | I | 11 657 589 | ||||||||
| 2020-01-09 | 3 | JK BioPharma Solutions, Inc | NRBO | Common Stock | D | 4 435 854 | ||||||||
| 2020-01-09 | 3 | JK BioPharma Solutions, Inc | NRBO | Common Stock | D | 3 418 182 | ||||||||
| 2020-01-09 | 3 | JK BioPharma Solutions, Inc | NRBO | Common Stock | D | 4 435 854 | ||||||||
| 2020-01-09 | 3 | JK BioPharma Solutions, Inc | NRBO | Common Stock | D | 4 435 854 | ||||||||
| 2020-01-09 | 3 | JK BioPharma Solutions, Inc | NRBO | Common Stock | D | 3 418 182 | ||||||||
| 2020-01-09 | 3 | JK BioPharma Solutions, Inc | NRBO | Common Stock | D | 3 418 182 | ||||||||
| 2020-01-09 | 3 | DONG-A ST CO., LTD | NRBO | Common Stock | D | 5 761 224 | ||||||||
| 2020-01-09 | 3 | DONG-A ST CO., LTD | NRBO | Common Stock | D | 5 761 224 | ||||||||
| 2020-01-09 | 3 | DONG-A ST CO., LTD | NRBO | Common Stock | D | 5 761 224 | ||||||||
| 2020-01-02 | 2019-12-30 | 4 | Kim Na Yeon Held by The E&Healthcare Investment Fund No. 7 | NRBO | Common Stock | I | 1 864 799 | 1 864 799 | ||||||
| 2020-01-02 | 2019-12-30 | 4 | Kim Na Yeon Held by The E&Healthcare Investment Fund No. 6 | NRBO | Common Stock | I | 1 121 190 | 1 121 190 | ||||||
| 2020-01-02 | 2019-12-30 | 4 | Kim Na Yeon Held by The E&Healthcare Investment Fund II | NRBO | Common Stock | I | 4 335 800 | 4 335 800 | ||||||
| 2020-01-02 | 2019-12-30 | 4 | Oh Jeong Gyun Held by spouse. | NRBO | Common Stock | I | 240 051 | 240 051 | ||||||
| 2020-01-02 | 2019-12-30 | 4 | Oh Jeong Gyun Held by JK BioPharma Solutions, Inc. | NRBO | Common Stock | I | 1 817 842 | 1 817 842 | ||||||
| 2020-01-02 | 2019-12-30 | 4 | Versavel Mark | NRBO | Stock Option (right to buy) | D | 0,63 | 45 724 | 45 724 | |||||
| 2020-01-02 | 2019-12-30 | 4 | Versavel Mark | NRBO | Stock Option (right to buy) | D | 0,63 | 297 206 | 297 206 | |||||
| 2019-07-26 | 2019-07-24 | 4 | LICHTINGER PEDRO | GEMP | Common Stock | D | 15 000 | 74 833 | ||||||
| 2019-07-26 | 2019-07-24 | 4 | SASSINE ANDY | GEMP | Common Stock | D | 15 000 | 151 264 | ||||||
| 2019-07-26 | 2019-07-24 | 4 | Reno Seth | GEMP | Common Stock | D | 100 000 | 118 286 | ||||||
| 2019-07-26 | 2019-07-24 | 4 | KOUSKY KENNETH W | GEMP | Common Stock | D | 15 000 | 26 935 | ||||||
| 2019-07-26 | 2019-07-24 | 4 | Gullans Steven R. Ph.D. | GEMP | Common Stock | D | 300 000 | 300 000 | ||||||
| 2019-07-26 | 2019-07-24 | 4 | Bisgaier Charles PhD | GEMP | Common Stock | D | 100 000 | 1 348 914 | ||||||
| 2018-05-24 | 2018-05-22 | 4 | Gullans Steven R. Ph.D. | GEMP | Employee Stock Option (right to buy) | D | 5,56 | 50 000 | 50 000 | |||||
| 2018-05-24 | 2018-05-22 | 4 | Gullans Steven R. Ph.D. | GEMP | Employee Stock Option (right to buy) | D | 5,56 | 50 000 | 50 000 | |||||
| 2018-05-03 | 2018-05-01 | 4 | Gullans Steven R. Ph.D. | GEMP | Employee Stock Option (right to buy) | D | 5,56 | 150 000 | 150 000 | |||||
| 2018-02-12 | 2018-02-08 | 4 | Gullans Steven R. Ph.D. Held by Excel Venture Fund II, L.P. | GEMP | Common Stock | I | 7,0000 | 71 429 | 500 | 930 252 | ||||
| 2018-02-12 | 2018-02-08 | 4 | Reno Seth | GEMP | Common Stock | D | 7,0000 | 14 286 | 100 | 18 286 | ||||
| 2018-01-30 | 2018-01-29 | 4 | LICHTINGER PEDRO | GEMP | Stock Option(right to buy) | D | 10,44 | 10 800 | 10 800 | |||||
| 2018-01-30 | 2018-01-29 | 4 | SASSINE ANDY | GEMP | Stock Option (right to buy) | D | 10,44 | 10 800 | 10 800 | |||||
| 2018-01-30 | 2018-01-28 | 4 | Bisgaier Charles PhD | GEMP | Stock Option (right to buy) | D | 10,10 | 48 000 | 48 000 | |||||
| 2018-01-30 | 2018-01-29 | 4 | Hawryluk P. Kent | GEMP | Stock Option (right to buy) | D | 10,44 | 10 800 | 10 800 | |||||
| 2018-01-30 | 2018-01-29 | 4 | KOUSKY KENNETH W | GEMP | Stock Option (right to buy) | D | 10,44 | 10 800 | 10 800 | |||||
| 2018-01-30 | 2018-01-29 | 4 | Gullans Steven R. Ph.D. | GEMP | Employee Stock Option (right to buy) | D | 10,44 | 60 000 | 60 000 | |||||
| 2018-01-30 | 2018-01-28 | 4 | Reno Seth | GEMP | Employee Stock Option (right to buy) | D | 10,10 | 48 000 | 48 000 | |||||
| 2018-01-30 | 2018-01-28 | 4 | MATHIESEN JEFFREY S | GEMP | Employee Stock Option (right to buy) | D | 10,10 | 48 000 | 48 000 | |||||
| 2018-01-30 | 2018-01-28 | 4 | Golden Lee Scott | GEMP | Employee Stock Option (right to buy) | D | 10,10 | 148 000 | 148 000 | |||||
| 2017-08-16 | 2017-08-14 | 4 | MATHIESEN JEFFREY S | GEMP | Employee Stock Option (right to buy) | D | 3,59 | −3 207 | 0 | |||||
| 2017-08-16 | 2017-08-14 | 4 | MATHIESEN JEFFREY S | GEMP | Common Stock | D | 3,5900 | 3 207 | 12 | 14 134 | ||||
| 2017-08-15 | 2017-08-10 | 4/A | MATHIESEN JEFFREY S | GEMP | Employee Stock Option (right to buy) | D | 3,59 | −3 000 | 45 093 | |||||
| 2017-08-15 | 2017-08-10 | 4/A | MATHIESEN JEFFREY S | GEMP | Common Stock | D | 3,5900 | 3 000 | 11 | 10 927 | ||||
| 2017-08-11 | 2017-08-10 | 4 | MATHIESEN JEFFREY S | GEMP | Employee Stock Option (right to buy) | D | 3,59 | −3 000 | 0 | |||||
| 2017-08-11 | 2017-08-10 | 4 | MATHIESEN JEFFREY S | GEMP | Common Stock | D | 3,5900 | 3 000 | 11 | 10 927 | ||||
| 2017-08-02 | 2017-07-31 | 4 | Bisgaier Charles PhD | GEMP | Employee Stock Option (right to buy) | D | 1,34 | −4 474 | 0 | |||||
| 2017-08-02 | 2017-07-31 | 4 | Bisgaier Charles PhD | GEMP | Common Stock | D | 1,3440 | 4 474 | 6 | 1 248 914 | ||||
| 2017-05-31 | 2017-05-30 | 4 | Gullans Steven R. Ph.D. | GEMP | Employee Stock Option (right to buy) | D | 10,26 | 60 000 | 60 000 | |||||
| 2017-03-29 | 2017-03-28 | 4 | Golden Lee Scott | GEMP | Employee Stock Option (right to buy) | D | 11,15 | 20 000 | 20 000 | |||||
| 2017-03-14 | 2017-03-10 | 4 | SASSINE ANDY | GEMP | Warrant to Purchase Common Stock | D | 10,40 | 9,4700 | 15 840 | 150 | 15 840 | |||
| 2017-03-14 | 2017-03-10 | 4 | SASSINE ANDY | GEMP | Common Stock | D | 9,4700 | 21 119 | 200 | 136 264 | ||||
| 2017-03-14 | 2017-03-10 | 4 | LICHTINGER PEDRO | GEMP | Warrant to Purchase Common Stock | D | 10,40 | 9,4700 | 7 920 | 75 | 7 920 | |||
| 2017-03-14 | 2017-03-10 | 4 | LICHTINGER PEDRO | GEMP | Common Stock | D | 9,4700 | 10 559 | 100 | 59 833 | ||||
| 2017-03-14 | 2017-03-10 | 4 | Hawryluk P. Kent Held by the P. Kent Hawryluk Revocable Trust | GEMP | Warrant to Purchase Common Stock | I | 10,40 | 9,4700 | 18 750 | 178 | 18 750 | |||
| 2017-03-14 | 2017-03-10 | 4 | Hawryluk P. Kent Held by the P. Kent Hawryluk Revocable Trust | GEMP | Common Stock | I | 9,4700 | 25 000 | 237 | 81 889 | ||||
| 2017-03-14 | 2017-03-10 | 4 | Gullans Steven R. Ph.D. Held by Excel Venture Fund II, L.P. | GEMP | Warrant to Purchase Common Stock | I | 10,40 | 9,4700 | 39 599 | 375 | 39 599 | |||
| 2017-03-14 | 2017-03-10 | 4 | Gullans Steven R. Ph.D. Held by Excel Venture Fund II, L.P. | GEMP | Common Stock | I | 9,4700 | 52 798 | 500 | 858 823 | ||||
| 2017-02-03 | 2017-02-01 | 4 | KOUSKY KENNETH W Held by BWA Gemphire Investment Group II, LLC | GEMP | Common Stock | I | −110 428 | 6 463 | ||||||
| 2017-02-03 | 2017-02-01 | 4 | KOUSKY KENNETH W Held by BWA Gemphire Investment Group, LLC | GEMP | Common Stock | I | −101 406 | 4 472 | ||||||
| 2016-11-29 | 2016-11-25 | 4 | Sooch Mina | GEMP | Employee Stock Option (right to buy) | D | 10,00 | 120 000 | 600 000 | |||||
| 2016-10-06 | 2016-10-05 | 4 | Golden Lee Scott | GEMP | Employee Stock Option (right to buy) | D | 10,80 | 126 000 | 126 000 | |||||
| 2016-10-03 | 2016-09-30 | 4 | Sooch Mina | GEMP | Employee Stock Option (right to buy) | D | 10,00 | 120 000 | 480 000 | |||||
| 2016-08-12 | 2016-08-10 | 4 | Bisgaier Charles PhD Held by Bisgaier Family, LLC | GEMP | 8% Convertible Subordinated Promissory Notes | I | 6,71 | 0 | ||||||
| 2016-08-12 | 2016-08-10 | 4 | Bisgaier Charles PhD Held by The Charles L. Bisgaier Trust | GEMP | Series A Convertible Preferred Stock | I | −59 561 | 0 | ||||||
| 2016-08-12 | 2016-08-10 | 4 | Bisgaier Charles PhD Held by The Charles L. Bisgaier Trust | GEMP | 8% Convertible Subordinated Promissory Notes | I | 6,71 | 0 | ||||||
| 2016-08-12 | 2016-08-10 | 4 | Bisgaier Charles PhD | GEMP | Common Stock | D | 10,0000 | 51 750 | 518 | 1 244 440 | ||||
| 2016-08-12 | 2016-08-10 | 4 | Bisgaier Charles PhD Held by Bisgaier Family, LLC | GEMP | Common Stock | I | 6,7059 | 19 228 | 129 | 19 228 | ||||
| 2016-08-12 | 2016-08-10 | 4 | Bisgaier Charles PhD Held by The Charles L. Bisgaier Trust | GEMP | Common Stock | I | 6,7059 | 16 144 | 108 | 82 220 | ||||
| 2016-08-12 | 2016-08-10 | 4 | Bisgaier Charles PhD Held by The Charles L. Bisgaier Trust | GEMP | Common Stock | I | 6,7059 | 6 515 | 44 | 66 076 | ||||
| 2016-08-12 | 2016-08-10 | 4 | Bisgaier Charles PhD Held by The Charles L. Bisgaier Trust | GEMP | Common Stock | I | 59 561 | 59 561 | ||||||
| 2016-08-12 | 2016-08-10 | 4 | MATHIESEN JEFFREY S | GEMP | 8% Convertible Subordinated Promissory Note | D | 6,71 | 0 | ||||||
| 2016-08-12 | 2016-08-10 | 4 | MATHIESEN JEFFREY S | GEMP | Common Stock | D | 10,0000 | 4 000 | 40 | 7 927 | ||||
| 2016-08-12 | 2016-08-10 | 4 | MATHIESEN JEFFREY S | GEMP | Common Stock | D | 6,7059 | 3 927 | 26 | 3 927 | ||||
| 2016-08-12 | 2016-08-10 | 4 | Gullans Steven R. Ph.D. Held by Excel Venture Fund II, L.P. | GEMP | 8% Convertible Subordinated Promissory Note | I | 6,71 | 0 | ||||||
| 2016-08-12 | 2016-08-10 | 4 | Gullans Steven R. Ph.D. Held by Excel Venture Fund II, L.P. | GEMP | Common Stock | I | 10,0000 | 500 000 | 5 000 | 806 025 | ||||
| 2016-08-12 | 2016-08-10 | 4 | Gullans Steven R. Ph.D. Held by Excel Venture Fund II, L.P. | GEMP | Common Stock | I | 6,7059 | 306 025 | 2 052 | 306 025 | ||||
| 2016-08-12 | 2016-08-10 | 4 | LICHTINGER PEDRO | GEMP | 8% Convertible Subordinated Promissory Note | D | 6,71 | 0 | ||||||
| 2016-08-12 | 2016-08-10 | 4 | LICHTINGER PEDRO | GEMP | Common Stock | D | 10,0000 | 10 000 | 100 | 49 274 | ||||
| 2016-08-12 | 2016-08-10 | 4 | LICHTINGER PEDRO | GEMP | Common Stock | D | 6,7059 | 39 274 | 263 | 39 274 | ||||
| 2016-08-12 | 2016-08-10 | 4 | SASSINE ANDY | GEMP | 8% Convertible Subordinated Promissory Notes | D | 6,71 | 0 | ||||||
| 2016-08-12 | 2016-08-10 | 4 | SASSINE ANDY | GEMP | Series A Convertible Preferred Stock | D | −75 080 | 0 | ||||||
| 2016-08-12 | 2016-08-10 | 4 | SASSINE ANDY | GEMP | Common Stock | D | 6,7059 | 31 853 | 214 | 115 145 | ||||
| 2016-08-12 | 2016-08-10 | 4 | SASSINE ANDY | GEMP | Common Stock | D | 6,7059 | 8 212 | 55 | 83 292 | ||||
| 2016-08-12 | 2016-08-10 | 4 | SASSINE ANDY | GEMP | Common Stock | D | 75 080 | 75 080 | ||||||
| 2016-08-12 | 2016-08-10 | 4 | Oniciu Carmen Daniela | GEMP | Series A Convertible Preferred Stock | D | −2 237 | 0 | ||||||
| 2016-08-12 | 2016-08-10 | 4 | Oniciu Carmen Daniela | GEMP | Common Stock | D | 6,7059 | 245 | 2 | 152 401 | ||||
| 2016-08-12 | 2016-08-10 | 4 | Oniciu Carmen Daniela | GEMP | Common Stock | D | 2 237 | 152 156 | ||||||
| 2016-08-12 | 2016-08-10 | 4 | Hawryluk P. Kent Held by the P. Kent Hawryluk Trust | GEMP | 8% Convertible Subordinated Promissory Notes | I | 6,71 | 0 | ||||||
| 2016-08-12 | 2016-08-10 | 4 | Hawryluk P. Kent Held by the P. Kent Hawryluk Trust | GEMP | Series A Convertible Preferred Stock | I | −7 457 | 0 | ||||||
| 2016-08-12 | 2016-08-10 | 4 | Hawryluk P. Kent Held by the P. Kent Hawryluk Revocable Trust | GEMP | Common Stock | I | 10,0000 | 25 000 | 250 | 56 889 | ||||
| 2016-08-12 | 2016-08-10 | 4 | Hawryluk P. Kent Held by the P. Kent Hawryluk Revocable Trust | GEMP | Common Stock | I | 6,7059 | 23 616 | 158 | 31 889 | ||||
| 2016-08-12 | 2016-08-10 | 4 | Hawryluk P. Kent Held by the P. Kent Hawryluk Revocable Trust | GEMP | Common Stock | I | 6,7059 | 816 | 5 | 8 273 | ||||
| 2016-08-12 | 2016-08-10 | 4 | Hawryluk P. Kent Held by the P. Kent Hawryluk Revocable Trust | GEMP | Common Stock | I | 7 457 | 7 457 | ||||||
| 2016-08-12 | 2016-08-10 | 4 | Reno Seth | GEMP | Common Stock | D | 10,0000 | 4 000 | 40 | 4 000 | ||||
| 2016-08-12 | 2016-08-10 | 4 | Sooch Mina Held by the Arvinder S. Sooch Trust | GEMP | 8% Convertible Subordinated Promissory Notes | I | 6,71 | 0 | ||||||
| 2016-08-12 | 2016-08-10 | 4 | Sooch Mina Held by the Arvinder S. Sooch Trust | GEMP | Series A Convertible Preferred Stock | I | −11 078 | 0 | ||||||
| 2016-08-12 | 2016-08-10 | 4 | Sooch Mina | GEMP | Common Stock | D | 10,0000 | 52 500 | 525 | 693 732 | ||||
| 2016-08-12 | 2016-08-10 | 4 | Sooch Mina Held by the Arvinder S. Sooch Trust | GEMP | Common Stock | I | 6,7059 | 27 141 | 182 | 39 431 | ||||
| 2016-08-12 | 2016-08-10 | 4 | Sooch Mina Held by the Arvinder S. Sooch Trust | GEMP | Common Stock | I | 6,7059 | 1 212 | 8 | 12 290 | ||||
| 2016-08-12 | 2016-08-10 | 4 | Sooch Mina Held by the Arvinder S. Sooch Trust | GEMP | Common Stock | I | 11 078 | 11 078 | ||||||
| 2016-08-12 | 2016-08-10 | 4 | Lowenschuss David | GEMP | Common Stock | D | 10,0000 | 11 120 | 111 | 806 247 | ||||
| 2016-08-12 | 2016-08-10 | 4 | KOUSKY KENNETH W Held by BWA Gemphire Investment Group II, LLC | GEMP | 8% Convertible Subordinated Promissory Notes | I | 6,71 | 0 | ||||||
| 2016-08-12 | 2016-08-10 | 4 | KOUSKY KENNETH W Held by BWA Gemphire Investment Group, LLC | GEMP | Series A Convertible Preferred Stock | I | −95 439 | 0 | ||||||
| 2016-08-12 | 2016-08-10 | 4 | KOUSKY KENNETH W | GEMP | Common Stock | D | 10,0000 | 1 000 | 10 | 1 000 | ||||
| 2016-08-12 | 2016-08-10 | 4 | KOUSKY KENNETH W Held by BWA Gemphire Investment Group II, LLC | GEMP | Common Stock | I | 6,7059 | 116 891 | 784 | 116 891 | ||||
| 2016-08-12 | 2016-08-10 | 4 | KOUSKY KENNETH W Held by BWA Gemphire Investment Group, LLC | GEMP | Common Stock | I | 6,7059 | 10 439 | 70 | 105 878 | ||||
| 2016-08-12 | 2016-08-10 | 4 | KOUSKY KENNETH W Held by BWA Gemphire Investment Group, LLC | GEMP | Common Stock | I | 95 439 | 95 439 | ||||||
| 2016-08-08 | 2016-08-04 | 4 | Bisgaier Charles PhD | GEMP | Employee Stock Option (right to buy) | D | 10,00 | 150 000 | 150 000 | |||||
| 2016-08-08 | 2016-08-04 | 4 | MATHIESEN JEFFREY S | GEMP | Employee Stock Option (right to buy) | D | 10,00 | 210 000 | 210 000 | |||||
| 2016-08-08 | 2016-08-04 | 4 | Gullans Steven R. Ph.D. | GEMP | Stock Option (right to buy) | D | 10,00 | 60 000 | 60 000 | |||||
| 2016-08-08 | 2016-08-04 | 4 | LICHTINGER PEDRO | GEMP | Stock Option (right to buy) | D | 10,00 | 60 000 | 60 000 | |||||
| 2016-08-08 | 2016-08-04 | 4 | SASSINE ANDY | GEMP | Stock Option (right to buy) | D | 10,00 | 60 000 | 60 000 | |||||
| 2016-08-08 | 2016-08-04 | 4 | Oniciu Carmen Daniela | GEMP | Employee Stock Option (right to buy) | D | 10,00 | 102 000 | 102 000 | |||||
| 2016-08-08 | 2016-08-04 | 4 | Hawryluk P. Kent | GEMP | Stock Option (right to buy) | D | 10,00 | 60 000 | 60 000 | |||||
| 2016-08-08 | 2016-08-04 | 4 | Reno Seth | GEMP | Employee Stock Option (right to buy) | D | 10,00 | 150 000 | 150 000 | |||||
| 2016-08-08 | 2016-08-04 | 4 | Sooch Mina | GEMP | Employee Stock Option (right to buy) | D | 10,00 | 360 000 | 360 000 | |||||
| 2016-08-08 | 2016-08-04 | 4 | Lowenschuss David | GEMP | Employee Stock Option (right to buy) | D | 10,00 | 78 000 | 78 000 | |||||
| 2016-08-08 | 2016-08-04 | 4 | KOUSKY KENNETH W | GEMP | Stock Option (right to buy) | D | 10,00 | 60 000 | 60 000 | |||||
| 2016-08-04 | 3 | Hawryluk P. Kent | GEMP | Common Stock | D | 64 124 | ||||||||
| 2016-08-04 | 3 | Hawryluk P. Kent | GEMP | Common Stock | D | 64 124 | ||||||||
| 2016-08-04 | 3 | Sooch Mina | GEMP | Common Stock | D | 1 282 464 | ||||||||
| 2016-08-04 | 3 | Sooch Mina | GEMP | Common Stock | D | 1 282 464 | ||||||||
| 2016-08-04 | 3 | Oniciu Carmen Daniela | GEMP | Common Stock | D | 299 838 | ||||||||
| 2016-08-04 | 3 | Oniciu Carmen Daniela | GEMP | Common Stock | D | 299 838 | ||||||||
| 2016-08-04 | 3 | Lowenschuss David | GEMP | Common Stock | D | 1 590 254 | ||||||||
| 2016-08-04 | 3 | Lowenschuss David | GEMP | Common Stock | D | 1 590 254 | ||||||||
| 2016-08-04 | 3 | Bisgaier Charles PhD | GEMP | Common Stock | D | 2 385 380 | ||||||||
| 2016-08-04 | 3 | Bisgaier Charles PhD | GEMP | Common Stock | D | 2 385 380 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
